MAR 11, 2015 02:54 PM PDT

Protein in the Brain Can 'Put the Brakes' On Binge Drinking

A new study led by University of North Carolina School of Medicine researchers has found that a naturally-occurring protein in the brain can act to suppress binge alcohol drinking, a major public health problem estimated to cost the U.S. more than $170 billion each year.

The study, published online by the journal Nature Neuroscience on March 9, was led by Thomas L. Kash, PhD, assistant professor in the departments of pharmacology and psychology and a member of UNC's Bowles Center for Alcohol Studies.

"Using a series of genetic and pharmacological approaches we identified how a compound in the brain, Neuropeptide Y (NPY), can suppress this dangerous behavior," Kash said.

"Specifically, we found that NPY acted in a part of the brain known as the extended amygdala (or bed nucleus of the stria terminalis) that we know is linked to both stress and reward. This anti-drinking effect was due to increasing inhibition (the brakes) on a specific population of cells that produce a ‘pro-drinking' molecule called corticotropin releasing factor (CRF). When we then mimicked the actions of NPY using engineered proteins, we were also able to suppress binge alcohol drinking in mice.

"Finally, we found that this anti-drinking NPY system is altered by long-term alcohol drinking in multiple species, suggesting that this may be either a marker or treatment for alcohol abuse," Kash said.

"The identification of where in the brain and how NPY blunts binge drinking, and the observation that the NPY system is compromised during early binge drinking prior to the transition to dependence, are novel and important observations," said study co-author Todd E. Thiele, Ph.D., professor of psychology at UNC and a member of the Bowles Center for Alcohol Studies. "What is particularly exciting is that these findings suggest that restoring NPY may not only be useful for treating alcohol use disorders, but may also protect some individuals from becoming alcohol dependent," said Thiele.

Source: UNC
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 20, 2019
Neuroscience
SEP 20, 2019
How to dial up or down emotional memories
Memories of traumatic experiences can resurface over and over again, causing great emotional distress. This is a hallmark symptom of psychiatric diseases such as PTSD, anxiety, and depression...
SEP 20, 2019
Health & Medicine
SEP 20, 2019
Don't touch the thermostat! Study shows how temperature impacts productivity and cognitive performance.
A new study from USC may have upped the stakes of office thermostat battles. The results of a study recently published in PLOS ONE demonstrated that temper...
SEP 20, 2019
Cell & Molecular Biology
SEP 20, 2019
Understanding the Spread of Parkinson's from the Gut to the Brain
Parkinson's disease, a neurodegenerative disorder impacting the brain, can begin in the gut....
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Does Microdosing Really Boost Productivity and Creativity?
Microdosing is the practice of ingesting very low doses of psychedelic substances, typically a twentieth of a recreational dose. In particular, Lysergic ac...
SEP 20, 2019
Drug Discovery & Development
SEP 20, 2019
Can LSD Treat Addiction?
Modern medicine commonly refers to addiction as a brain disease caused by drugs and other negative stimuli. However, evidence is surmounting that addiction...
SEP 20, 2019
Genetics & Genomics
SEP 20, 2019
Modified CRISPR Can Manipulate Gene Activity in Neurons
There are challenges to working with nerve cells in the lab, which can create research bottlenecks in the study of neurological disease....
Loading Comments...